| Literature DB >> 33779352 |
William S Frye1, Lauren Gardner1, Jonathan M Campbell2, Jennifer M Katzenstein1.
Abstract
The coronavirus pandemic and in-person contact restrictions necessitated rapid implementation of telehealth, specifically videoconferencing, to provide essential care to patients. This study surveyed 25 pediatric behavioral health providers at a single center during their first month of utilizing telehealth during coronavirus disease 2019 (COVID-19). Twenty-one participants completed a pre-questionnaire distributed prior to telehealth service delivery, and 23 providers completed a post-questionnaire approximately three weeks later. Results indicate the majority of behavioral health providers had no experience providing telehealth services prior to COVID-19. The majority of participating behavioral health providers utilized telehealth to provide pediatric patient care within the first month of access to telehealth. Participants' confidence in their ability to provide telehealth services significantly increased within the first month of implementation, regardless of previous training in telehealth. This study identified differences between anticipated and actual barriers to treatment, with technological issues identified as the largest actual barrier to service delivery. Participants indicated a preference for in-person service delivery, which they reported allows for better rapport-building, behavioral observations, reduced technological barriers, and fewer distractions. However, most participants reported they intend to continue utilizing telehealth for certain types of behavioral health services (e.g., diagnostic interviews and outpatient therapy) after the pandemic has subsided.Entities:
Keywords: COVID-19; academic medical centers; coronavirus; program implementation; telehealth
Mesh:
Year: 2021 PMID: 33779352 PMCID: PMC9194499 DOI: 10.1177/13674935211007329
Source DB: PubMed Journal: J Child Health Care ISSN: 1367-4935 Impact factor: 1.896
Telehealth experiences after rapid implementation due to COVID-19 (N = 23).
| Variable | n | % | Min | Max | M | SD |
|---|---|---|---|---|---|---|
| Direct care | 0 | 61 | 23.9 | 17.3 | ||
| Supervised trainees | 0 | 40 | 7.4 | 8.7 | ||
| Outpatient therapy | 12 | 52.2 | ||||
| Diagnostic interview | 10 | 43.4 | ||||
| Diagnostic evaluation | 4 | 17.4 | ||||
| Inpatient/C-L | 4 | 17.4 | ||||
| Providing assessment feedback | 4 | 17.4 | ||||
| Medication management | 2 | 8.7 | ||||
| Telehealth | 0 | 0 | ||||
| In-person | 19 | 82.6 | ||||
| Depends on patient | 2 | 8.7 | ||||
| No response | 2 | 8.7 | ||||
| Yes | 18 | 78.3 | ||||
| No | 5 | 21.7 | ||||
Note: Categories are not mutually exclusive, and multiple codes are possible per participant; therefore, percentages total more than 100%.
Anticipated and actual barriers to services.
| Anticipated barriers pretest | Actual barriers posttest | |||
|---|---|---|---|---|
| ( | ( | |||
| Platform limitations | 9 | 75.0 | 22 | 95.7 |
| Patient engagement | 8 | 66.7 | 12 | 52.2 |
| Providing valid services | 4 | 33.3 | 7 | 30.4 |
| Experience/confidence | 3 | 25.0 | 6 | 26.1 |
| Patient access | 3 | 25.0 | 12 | 52.2 |
| Patient safety | 2 | 16.7 | 2 | 8.7 |
| Billing and productivity | 2 | 16.7 | 6 | 26.1 |
| No identified concerns/barriers [ | 9 | 42.9 | 0 | 0 |
Note: a= 12 of 21 respondents responded to the open-ended question regarding barriers.
b= Nine of 21 respondents did not identify concerns or barriers during the pretest. Categories are not mutually exclusive, and multiple codes are possible per participant; therefore, percentages total more than 100%.